Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation

MLA

Naveen L. Pereira, et al. “Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation.” Journal of Cardiac Failure, vol. 27, May 2021, pp. 542–51. EBSCOhost, https://doi.org/10.1016/j.cardfail.2021.01.019.

APA

Naveen L. Pereira, Walter K. Kremers, Chaim Locker, Alfredo L. Clavell, Hilmi Alnsasra, Amir Lerman, Brooks S. Edwards, Alexandros Briasoulis, Byron H. Smith, Rabea Asleh, Sudhir S. Kushwaha, John M. Stulak, Richard C. Daly, & Camden L. Lopez. (2021). Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation. Journal of Cardiac Failure, 27, 542–551. https://doi.org/10.1016/j.cardfail.2021.01.019

Chicago

Naveen L. Pereira, Walter K. Kremers, Chaim Locker, Alfredo L. Clavell, Hilmi Alnsasra, Amir Lerman, Brooks S. Edwards, et al. 2021. “Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation.” Journal of Cardiac Failure 27 (May): 542–51. doi:10.1016/j.cardfail.2021.01.019.